These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7915128)

  • 1. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
    Brooks DP; Mitchell MP; Short BG; Ruffolo RR; Nichols AJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1243-7. PubMed ID: 1675291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
    Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
    Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
    Gretler DD; Jones KC; Murphy MB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):491-8. PubMed ID: 1346635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.
    Meyer ME; Van Hartesveldt C; Potter TJ
    Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.
    Ackerman DM; Blumberg AL; McCafferty JP; Sherman SS; Weinstock J; Kaiser C; Berkowitz B
    Fed Proc; 1983 Feb; 42(2):186-90. PubMed ID: 6130004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.